Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE
- PMLiVE

Pharmaceutical Market Europe – March 2023

How congresses are boosting their impact and engagement; improving cardiovascular disease awareness; the importance of addressing health inequalities

- PMLiVE

Pharmaceutical Market Europe – February 2023

World Cancer Day – uniting the global cancer community, Innovation in healthcare, Life sciences reimagined – reassessing future healthcare priorities

- PMLiVE

Pharmaceutical Market Europe – January 2023

Healthcare’s rising challenges and the use of digital innovation. ASH 2022: five trends driving changes in haematology, the benefits of biosimilars

- PMLiVE

Pharmaceutical Market Europe – December 2022

Sustainability and corporate social responsibility; addressing cardiovascular disease with sustainable interventions; PMEAs 2022: A celebration of healthcare excellence

- PMLiVE

Pharmaceutical Market Europe – November 2022

The age of diversity, equality and inclusion; the patient voice in digital transformation; how telemonitoring can improve patient treatment

- PMLiVE

Pharmaceutical Market Europe – October 2022

ESMO 2022: changing the future of oncology; the complexities of current generation CAR-T therapies; why community engagement is vital

- PMLiVE

Pharmaceutical Market Europe – September 2022

The importance of support programmes to improve patient health; the fight against antimicrobial resistance; future-proofing pharma supply chains

- PMLiVE

Pharmaceutical Market Europe – July/ August 2022

A creative awakening – bringing innovation to patients; Parkinson’s disease and the microbiome; Rare diseases – changing the standard of care

- PMLiVE

Pharmaceutical Market Europe – June 2022

A creative awakening – bringing innovation to patients; Parkinson’s disease and the microbiome; Rare diseases – changing the standard of care

- PMLiVE

Pharmaceutical Market Europe – May 2022

How patients and HCPs are powering a new era of launch excellence; Tackling life sciences disputes; Clinical trials and the patient perspective

- PMLiVE

Pharmaceutical Market Europe – April 2022

How patients and HCPs are powering a new era of launch excellence; Tackling life sciences disputes; Clinical trials and the patient perspective

- PMLiVE

Pharmaceutical Market Europe – March 2022

Unleashing the power of medical affairs, Takeda looks at the challenges facing combination treatments, MHRA: COVID-19 vaccines, treatments and tests